These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 341102)

  • 1. Some observations on patient compliance in an antidepressive trial.
    Witts DJ; Mulgirigama D; Turner P; Pare CM
    Postgrad Med J; 1977; 53 Suppl 4():136-8. PubMed ID: 341102
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response.
    Mulgirigama LD; Pare CM; Turner P; Wadsworth J; Witts DJ
    Postgrad Med J; 1977; 53 Suppl 4():155-9. PubMed ID: 341104
    [No Abstract]   [Full Text] [Related]  

  • 3. Tyramine pressor responses and plasma levels during tricyclic antidepressant therapy.
    Mulgirigama LD; Pare CM; Turner P; Wadsworth J; Witts DJ
    Postgrad Med J; 1977; 53 Suppl 4():30-4. PubMed ID: 341108
    [No Abstract]   [Full Text] [Related]  

  • 4. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
    Ridges AP
    Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
    Drago F; Motta A; Grossi E
    J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
    Zapletálek M; Hübsch T; Zbytovský J; Polácková J; Kindernayovä H
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):323-34. PubMed ID: 333568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled double-blind clinical trial between maprotiline and amitriptyline in depressive illness.
    Okasha A; Sadek A
    J Egypt Med Assoc; 1976; 59(5-6):557-62. PubMed ID: 801741
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacotherapy of masked depression].
    Kielholz VP
    Wien Med Wochenschr; 1975 May; 125(21):327-9. PubMed ID: 3030
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomipramine plasma level and clinical response.
    Broadhurst AD; James HD; Corte LD; Heeley AF
    Postgrad Med J; 1977; 53 Suppl 4():139-45. PubMed ID: 600891
    [No Abstract]   [Full Text] [Related]  

  • 12. Maprotiline and fluphenazine/nortriptyline in depression.
    O'Hara H; O'Hara J; Valle-Jones JC; McGhie RL; Brodie NH; Schiff AA
    Practitioner; 1978 Sep; 221(1323):419-23. PubMed ID: 366595
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients.
    Lehmann HE; Pecknold JC; Ban TA; Orbach L
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):463-8. PubMed ID: 816604
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma concentrations of clomipramine and its N-desmethyl metabolite in depressive patients following treatment with various dosage regimes of clomipramine.
    Jones RB; Luscombe DK
    Postgrad Med J; 1977; 53 Suppl 4():63-76. PubMed ID: 758091
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
    Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression.
    Ridges AP; Bishop FM; Lawton K; Goldberg IJ
    Postgrad Med J; 1980; 56 Suppl 1():37-41. PubMed ID: 6156444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between clinical response, plasma levels and side-effects of clomipramine (Anafranil) in general practitioner trials.
    Miller P; Luscombe DK; Jones RB; Seldrup J; Beaumont G; John V
    J Int Med Res; 1977; 5(1 Suppl):108-18. PubMed ID: 863079
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood concentrations of maprotiline in depressive patients].
    Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
    Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.